课题基金 / 基金详情

Regulation of ocular angiogenesis by microRNAs

Regulation of ocular angiogenesis by microRNAs
microRNA对眼部血管生成的调节
批准号:
8589873
负责人:
Shusheng Wang
金额:
$35.77万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-09-01 至 2016-08-31

项目摘要

项目成果

Shusheng Wang的其他基金

相似基金

相关文献

中文摘要
翻译
描述(申请人提供):本项目重点研究眼部血管生成的microRNA机制。血管生成在眼睛发育和许多主要的致盲视网膜疾病中起着核心作用,如年龄相关性黄斑变性(AMD)。microRNAs作为转录后调节基因表达的内源性小RNA的发现,彻底改变了我们对遗传途径网络的理解,并引发了大量研究,以探索microRNA治疗多种疾病的方法。我们广泛的长期目标是:(A)了解特定的microRNAs如何调节眼血管发育的机制,以及(B)破译这些microRNAs在血管视网膜病变中的作用。我们最近的研究表明,一种特异性的microRNA miR-126是一种内皮细胞特异性的microRNA,它调节血管生成途径,以响应血管内皮生长因子(VEGF)和成纤维细胞生长因子(FGF)。我们也有初步数据表明miR-126在视网膜/脉络膜内皮细胞中特异表达,是视网膜血管生成所必需的。我们的组织假说是,miR-126通过调节多条血管生成通路,在眼部血管生成和新生血管性AMD的发病机制中起着关键的调节作用。作为一种具有多种调节功能的小分子,miR-126将成为治疗失明视网膜病变的一个有吸引力的靶点。明确miR-126在视网膜/脉络膜中的表达模式和调控机制。具体目的二是确定miR-126调节视网膜血管发育的要求和机制。具体目的三是确定miR-126在激光诱导的脉络膜新生血管模型中调节新生血管的机制。
英文摘要
DESCRIPTION (provided by applicant): This project focuses on microRNA mechanisms on ocular angiogenesis. Angiogenesis plays a central role in eye development and also many major blinding retinal diseases, such as age related macular degeneration (AMD).The discovery of MicroRNAs as small endogenous RNAs regulating gene expression post-transcriptionally has revolutionized our understanding of genetic pathway networks, and ignited tremendous studies to explore microRNA therapeutics for numerous diseases. Our broad long-term goals are: (a) to understand the mechanisms of how specific microRNAs regulate ocular vascular development and (b) to decipher the roles of these microRNAs in vascular retinopathies. Our recent studies show that a specific microRNA, miR-126, is an endothelial cell specific microRNA regulating angiogenic pathways in response to vascular endothelial growth factor (VEGF) and fibroblast growth factor (FGF). We also have preliminary data that miR-126 is expressed specifically in the endothelium in the retina/choroid, and is required for sprouting retinal angiogenesis. Our organizing hypothesis for this proposal is that by regulating multiple angiogenic pathways miR-126 plays a critical regulatory role in ocular angiogenesis and in the pathogenesis of neovascular AMD. As a small molecule with multiple regulatory functions, miR-126 would be an attractive therapeutic target for blinding vascular retinopathies. Specific Aim I is to define the expression pattern and regulation mechanism of miR-126 in the retina/choroid. Specific Aim II is to identify the requirement and mechanism whereby miR-126 regulates retinal vascular development. Specific Aim III is to determine the mechanism by which miR-126 regulates neovascularization in a laser induced choroidal neovascularization model.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanistic study and therapeutic development for subretinal fibrosis
  • 批准号:
    10749681
  • 项目类别:
  • 资助金额:
    $38.82万
  • 财政年份:
    2023
  • 负责人:
    Shusheng Wang
  • 依托单位:
Role of long noncoding RNAs in human ocular angiogenesis
  • 批准号:
    9330862
  • 项目类别:
  • 资助金额:
    $37.63万
  • 财政年份:
    2016
  • 负责人:
    Shusheng Wang
  • 依托单位:
Role of long noncoding RNAs in human ocular angiogenesis
  • 批准号:
    9762935
  • 项目类别:
  • 资助金额:
    $37.63万
  • 财政年份:
    2016
  • 负责人:
    Shusheng Wang
  • 依托单位:
Regulation of ocular angiogenesis by microRNAs
  • 批准号:
    8531950
  • 项目类别:
  • 资助金额:
    $35.74万
  • 财政年份:
    2011
  • 负责人:
    Shusheng Wang
  • 依托单位:
国内基金
海外基金
眼表菌群影响糖尿病患者干眼发生的人群流行病学研究
  • 批准号:
    82371110
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    邹海东
  • 依托单位:
趋化因子及其受体介导的血源性干/祖细胞及血管内皮细胞在新生血管性眼病中免疫病理机制及干预
  • 批准号:
    30972712
  • 项目类别:
    面上项目
  • 资助金额:
    30.0万元
  • 批准年份:
    2009
  • 负责人:
    陆培荣
  • 依托单位:
趋化因子及其受体与新生血管性眼病的形成机制及干预研究
  • 批准号:
    30771978
  • 项目类别:
    面上项目
  • 资助金额:
    8.0万元
  • 批准年份:
    2007
  • 负责人:
    陆培荣
  • 依托单位: